甲氨蝶呤联合补益肝肾汤治疗类风湿性关节炎合并骨质疏松症的临床效果研究

2021-03-24 22:26:54陈正龙王娴
中国医学创新 2021年27期
关键词:类风湿性关节炎

陈正龙 王娴

【摘要】 目的:探究甲氨蝶呤聯合补益肝肾汤治疗类风湿性关节炎(RA)伴骨质疏松症患者的临床效果。方法:选择2017年12月-2020年1月于本院治疗的120例RA合并骨质疏松症患者。按照双盲法分组标准将患者分为常规组和观察组,每组60例。常规组予以甲氨蝶呤片联合雷公藤多苷片治疗,观察组采用甲氨蝶呤片联合补益肝肾汤治疗。比较两组治疗效果、临床指标、实验室指标、骨密度和不良反应发生情况。结果:观察组总有效率高于常规组,差异有统计学意义(P<0.05)。治疗后,观察组晨僵时间短于常规组,关节疼痛评分低于常规组,关节压痛数和关节肿胀数均少于常规组,差异均有统计学意义(P<0.05)。治疗后,观察组ESR、hs-CRP、RF水平均低于常规组,差异均有统计学意义(P<0.05)。治疗后,观察组股骨颈、腰椎骨密度均高于常规组,差异均有统计学意义(P<0.05)。观察组不良反应发生率低于常规组,差异有统计学意义(P<0.05)。结论:补益肝肾汤治疗RA伴骨质疏松症作用显著,安全性高,值得临床推广。

【关键词】 骨质疏松症 不良反应 类风湿性关节炎 骨密度 补益肝肾汤

Study on Clinical Effect of Methotrexate Combined with Buyi Ganshen Decoction in Treating Rheumatoid Arthritis Complicated with Osteoporosis/CHEN Zhenglong, WANG Xian. //Medical Innovation of China, 2021, 18(27): 0-077

[Abstract] Objective: To explore the clinical effect of Methotrexate combined with Buyi Ganshen Decoction in the treatment of rheumatoid arthritis (RA) complicated with osteoporosis. Method: A total of 120 RA patients complicated with osteoporosis treated in our hospital from December 2017 to January 2020 were selected. According to the double-blind grouping standard, the patients were divided into routine group and observation group, 60 cases in each group. The routine group was treated with Methotrexate Tablets combined with Tripterygium Glycosides Tablets, the observation group was treated with Methotrexate Tablets combined with Buyi Ganshen Decoction. The treatment effect, clinical indicators, laboratory indicators, bone mineral density and the incidence of adverse reactions were compared between the two groups. Result: The total effective rate of the observation group was higher than that of the routine group, the difference was statistically significant (P<0.05). After treatment, the morning stiffness time of the observation group was shorter than that of the routine group, the joint pain score was lower than that of the routine group, the number of joint tenderness and joint swelling were less than those of the routine group, the differences were statistically significant (P<0.05). After treatment, the levels of ESR, hs-CRP and RF in the observation group were lower than those in the routine group, the differences were statistically significant (P<0.05). After treatment, the bone density of femoral neck and lumbar vertebra in the observation group were higher than those in the routine group, the differences were statistically significant (P<0.05). The incidence of adverse reactions in the observation group was lower than that in the routine group, the difference was statistically significant (P<0.05). Conclusion: Buyi Ganshen Decoction has significant effect and high safety in the treatment of RA complicated with osteoporosis, which is worthy of clinical promotion.

[Key words] Osteoporosis Adverse reactions Rheumatoid arthritis Bone mineral density Buyi Ganshen Decoction

First-author’s address: Huangshi Second Hospital, Huangshi 435002, China

doi:10.3969/j.issn.1674-4985.2021.27.019

类风湿性关节炎(RA)属于自身免疫性疾病,关节滑膜炎與关节病变为患者主要病理表现[1]。资料显示,RA常合并骨质疏松症,易导致严重残疾,且患者发病2年内会出现不可逆骨关节破坏,2年致残率高达50%[2]。由此可见,制定科学、合理的治疗方法对此病意义重大。目前临床常采用补钙、免疫抑制剂、非甾体抗炎药治疗RA伴骨质疏松症,尽管能控制患者临床症状,避免骨质破坏,但长期使用副作用多,且远期效果不理想。……

登录APP查看全文

猜你喜欢
类风湿性关节炎
类风湿因子及抗环瓜氨酸多肽抗体检测在类风湿关节炎中临床意义
医学信息(2017年1期)2017-02-28 00:21:02
双藤痹痛凝胶对CIA大鼠外周血调节性T细胞的作用研究
类风湿性关节炎发病机制的研究进展
甲氨蝶呤与来氟米特治疗类风湿性关节炎的临床疗效和安全性观察
类风湿性关节炎膝关节高频彩色多普勒超声临床应用评价
护理干预对类风湿性关节炎患者疼痛的影响研究
联合检测类风湿因子、抗CCP抗体、免疫球蛋白对辅助诊断类风湿性关节炎的作用
来氟米特与美洛昔康治疗类风湿性关节炎的效果与安全性研究
甲氨蝶呤联合雷公藤多甙片治疗类风湿性关节炎疗效及安全性研究